معرفی
Ling Yang, PhD, is an Associate Professor in the Department of Medical Genetics and Molecular Biochemistry at the Lewis Katz School of Medicine, Temple University. Her research integrates computational and experimental approaches to study the role of noncoding RNAs in liver diseases and atherosclerosis, with a focus on developing RNA-based therapeutics.
Research Interests:
- Molecular pathology of liver diseases, particularly non-alcoholic fatty liver disease (NAFLD) and hepatocellular carcinoma
- Role of long non-coding RNAs (lncRNAs) and circular RNAs (circRNAs) in cholesterol metabolism and atherosclerosis
- Development of RNA-targeted therapies using AAV, siRNA, and antisense oligonucleotides
Her work employs bioinformatics, genetics, genomics, molecular and cellular biology, and CRISPR-mediated genome engineering to dissect regulatory networks in disease pathogenesis.
Honors & Awards:
- DOD Discovery Award (2021)
- NHLBI K22 Career Transition Award (2018)
- NHLBI Director’s Award (2017)
- NHLBI Orloff Science Award (2017)
- Young Investigator Award, NIH Asian and Pacific Islander American Organization (2016)
Dr. Yang has been supported by competitive grants and awards, indicating strong recognition in her field. While specific advisees are not listed, her active laboratory suggests ongoing mentorship. Her research is highly translational, aiming to bridge molecular discovery with therapeutic innovation.
She is affiliated with a well-established research lab focused on RNA biology and metabolic disease, contributing to both basic science and clinical applications in hepatology and cardiovascular disease.
حوزههای پژوهشی
